Company Filing History:
Years Active: 1993-1996
Title: Kristin Esenther: Innovator in Immunosuppressive Therapies
Introduction
Kristin Esenther is a notable inventor based in Ashland, MA (US). She has made significant contributions to the field of immunology, particularly in the development of therapies aimed at managing autoimmune diseases and improving transplant outcomes. With a total of two patents to her name, her work is paving the way for advancements in medical treatments.
Latest Patents
Kristin's latest patents include a method for suppressing the immune response associated with psoriasis. This invention focuses on the use of Ruthenium Red as an immunosuppressive agent to prevent or significantly reduce graft rejection in organ and bone marrow transplantation. Additionally, Ruthenium Red can serve as an immunosuppressant drug for T lymphocyte-mediated autoimmune diseases, such as diabetes. Furthermore, it may be beneficial in alleviating psoriasis and contact dermatitis. Another patent highlights the use of Ruthenium Red as an immunosuppressive agent, reiterating its potential in organ and bone marrow transplantation and its application in treating autoimmune diseases.
Career Highlights
Kristin Esenther is currently associated with Procept Corporation, where she continues to innovate and contribute to the field of immunology. Her work is characterized by a commitment to improving patient outcomes through scientific research and development.
Collaborations
Kristin collaborates with various professionals in her field, including her coworker Donard S Dwyer. Their combined expertise enhances the research and development efforts at Procept Corporation.
Conclusion
Kristin Esenther's contributions to immunology through her innovative patents demonstrate her dedication to advancing medical science. Her work with Ruthenium Red has the potential to significantly impact the treatment of autoimmune diseases and improve transplant success rates.